A methodological framework for real-world performance studies of clinical variant classification platforms at early organizational stages.

A structured methodological framework enables early-stage performance assessment of clinical variant classification platforms, demonstrated on 97 cases across three versions.

• Why it matters: Accurate performance evaluation of variant classification systems is crucial for rare-disease genomics but is hindered by inadequate methods at organizational early stages, especially when peer disagreements are common.
• What they did: The authors developed a four-component framework featuring a multi-layer performance model, evidence-weighted ground truth, a six-category disposition taxonomy, and a phased pathway, applied to Helena Bioinformatics’ platform.
• The result: This framework operationalizes early performance studies, facilitating independent adaptation and advancing toward regulatory readiness, despite current limitations like single-platform testing and potential conflicts of interest.